Reaction to WTO TRIP's waiver "outcome"

Published: 4th May 2022

Responding to the WTO’s published ‘outcome’ of negotiations over a waiver of Trade-Related aspects of Intellectual Property (TRIPS), Max Lawson, Head of Inequality Policy for Oxfam and co-chair of the People's Vaccine Alliance, said:

"This text is a recognition that WTO rules on intellectual property are a clear barrier to ensuring people get the vaccines, tests, and treatments they need. It is a tragedy that it has taken almost two years and millions of deaths to reach this point and a travesty that the action proposed today falls well short of what is needed.

"The text as it stands continues to place pharmaceutical corporate interests over the needs of global health. It adds more unnecessary barriers than existed before negotiations began and failure to act now on treatments and tests is inexcusable. 

"This is not the TRIPS waiver supported by over 100 governments. It is not endorsed by any member other than the EU. And it is utterly insufficient for a pandemic that has killed an estimated 20 million people and rising. 

“WTO member states must urgently deliver a genuine intellectual property waiver that will turn the tide on global vaccine, test, and treatment inequality and make a difference to controlling this virus. If WTO negotiations cannot deliver that after two years of a deadly pandemic, then we must admit that the institution is not fit for purpose.”

Notes to editors

The People’s Vaccine Alliance is a coalition of nearly 100 organizations and networks, supported by Nobel Laureates, health experts, economists, Heads of States, faith leaders and activists, working together for a People’s Vaccine, available free of charge to everyone, everywhere.

Contact information

People's Vaccine Media Team |
Jade Tenwick in Belgium | | +32 473 56 22 60
Sarah Dransfield in the UK | | 0044 (0)7884 114825

For updates, please follow @NewsFromOxfam and @Oxfam 

Please support Oxfam's Coronavirus Response Appeal.